11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Juha O. Rinne(Turku University Hospital), David J. Brooks(Imperial College London), Martin N. Rossor(University College London), Nick C. Fox(University College London), Roger Bullock, William E. Klunk(University of Pittsburgh Medical Center), Chester A. Mathis(University of Pittsburgh Medical Center), Kaj Blennow(Sahlgrenska University Hospital), Jerome Barakos(California Pacific Medical Center), Aren Okello(Imperial College London), Sofia Rodriguez Martinez de Liano(Imperial College London), Enchi Liu(Janssen (United States)), Martin Koller, Keith M. Gregg(Janssen (United States)), Dale Schenk, Ronald S. Black(Pfizer (United States)), Michael Grundman
The Lancet Neurology
February 27, 2010
Cited by 695

Abstract


Related Papers

No related papers found

Powered by citation graph analysis